| 前收市價 | 0.9050 |
| 開市 | 0.8953 |
| 買盤 | 0.8475 x 200 |
| 賣出價 | 0.8919 x 100 |
| 今日波幅 | 0.8000 - 0.9136 |
| 52 週波幅 | 0.8000 - 2.1000 |
| 成交量 | |
| 平均成交量 | 1,026,531 |
| 市值 | 96.926M |
| Beta 值 (5 年，每月) | -0.24 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.3200 |
| 業績公佈日 | 2024年5月09日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 3.75 |
Insider MonkeyOptiNose, Inc. (NASDAQ:OPTN) Q4 2023 Earnings Call Transcript
OptiNose, Inc. (NASDAQ:OPTN) Q4 2023 Earnings Call Transcript March 7, 2024 OptiNose, Inc. beats earnings expectations. Reported EPS is $-9.0E-5, expectations were $-0.1. OPTN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. […]
ZacksOptiNose (OPTN) Reports Q4 Loss, Lags Revenue Estimates
OptiNose (OPTN) delivered earnings and revenue surprises of 10% and 0.18%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksZevra Therapeutics (ZVRA) Soars 6.6%: Is Further Upside Left in the Stock?
Zevra Therapeutics (ZVRA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
